Axsome Therapeutics, Inc.
$199.02
-7.25 (-3.51%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -15.2%
- 3 Months
- -15.1%
- YTD
- +9.0%
- 1 Year
- +63.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 42.9%
- Largest decline max drawdown, since Aug 2025
- -22.0%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.35
Own AXSM?
See how AXSM contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.